Abbvie Inc
NYSE: ABBV
$182.43
+$0.63 (+0.3%)
Closing Price on May 22, 2025
ABBV Stock Chart and Intraday Price
ABBV Stock Data
| Asset Type | Stock |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 316,039.17M USD |
| Shares Outstanding | 1,766,470,000 |
ABBV Articles
The first quarter of this year reminded optimistic investors that stocks don’t only go up. Trade war tensions, recession worries, and other factors could spur a market crash in 2025. Instead of...
Published:
Dividend stocks are a foundational building block for creating a retirement portfolio, offering a reliable income stream and potential for capital appreciation. By investing in companies that...
Published:
Live Updates Live Coverage Has Ended Pharmaceutical Stocks are Still Erasing Earlier Losses 11:44 am Following the initial shock from President Trump’s drug cost announcement, many of the top...
Published:
Income-focused investors can take the time and trouble to pick individual stocks, or they can just buy an exchange traded fund (ETF) and make the process much easier. If safety is your priority but...
Published:
Dividend stock investing offers retirees a dependable way to generate passive income, ensuring financial stability in a time when fixed income options like Social Security often fall short. ...
Published:
These five Dividend Aristocrats have the least negligible impact from the tariffs and are ideal for passive income investors.
Published:
Four healthcare dividend stocks with significant upside potential and safe dividends look like outstanding ideas for investors worn out from tariff-related volatility.
Published:
If you want a way to combine steady income, stability, and diversification, an exchange-traded fund (ETF) can deliver all three. The iShares Core High ETF (NYSEARCA:HDV) is worth looking into since...
Published:
Yesterday’s wild rally in the stock market where $5.5 trillion in value following President Trump hitting a 90-day pause on his tariffs, exemplifies the dramatic swings investors have experienced...
Published:
Investing isn’t easy, and given the current market volatility, retail investors are on edge, worrying about their portfolios. About 20% of the S&P 500 stocks hit a 52-week low before the tariff...
Published:
Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.
Published:
In the 2020s, there are plenty of yield-focused exchange traded funds (ETFs) to choose from, and they’re not all created equal. Two popular dividend funds in particular — the Schwab U.S. Dividend...
Published:
Last Updated:
Forget the old adage “it takes money to make money.” In the stock market, even a measly $500 can kickstart a fortune. Time, not a fat wallet, is the real MVP here. With the right picks, that...
Published:
If you work in the biotech industry, you might know the name Alex Denner. If not, his name probably doesn’t ring a bell. Denner is the CEO and CIO of Sarissa Capital Management, a Greenwich-based...
Published:
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Published:
